Background: Ritonavir (RTV) and atazanavir sulfate (ATV) are protease inhibitor and RTV mostly used as a booster for increasing the bioavailability of other protease inhibitors like ATV. Aims: Quality assessment of the new dosage form of RTV and ATV i.e., tablets is very essential and hence this work deals with to develop sensitive, simple and precise method for simultaneous estimation of ATV and RTV in tablet dosage form by absorbance correction method. Materials and Methods: The present work was carried out on Shimadzu Ultraviolate(UV)-1700 double beam spectrophotometer with 1 cm path length supported by S Shimadzu, model-1700(Japan), UV-Probe software, version 2.31 was used for spectral measurements with 10 mm matched quartz cells. Standard ATV and RTV were supplied by Cipla Pharmaceutical Ltd. Methanol was purchased from Finar Chemicals Pvt. Ltd. Results and Conclusion: The λ max or the absorption maxima for ATV and RTV were found to be 279 and 240 nm, respectively in methanol as solvent. The drugs follow Beer-Lambert's law in the concentration range 30-90 and 10-30 μg/mL for ATV and RTV, respectively. The percentage recovery was found to be 100-100.33% and 100-101.5% for ATV and RTV, respectively. The method was validated for different parameters as per the International Conference for Harmonization Guidelines.
Introduction
], an azapeptide is the 7 th protease inhibitor used in the treatment of human immunodeficiency virus type II infection. It is official in Indian Pharmacopeia(IP). [1] Ritonavir (RTV) chemically is (5S,_8S,_10S,_11S)-10-hydroxy-2-methyl-5-(1-methyl ethyl)-1- [2- (1-methyl ethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid 5-thiazolyl methylester [ Figure 2 ]. It is official in IP [2] , USP [3] , BP. [4] Both the drugs were used as antiretroviral agents. ATV is a known substrate for both hepatic metabolizing enzyme cytochrome P450 and intestinal drug efflux pump, P-glycoprotein so have low oral bioavailability. So co-administration of a small dose of RTV is recommended as booster.Literature survey revealed that ATV and RTV was quantitatively assayed in biological fluids either individually or in the presence of other retroviral drugs using the liquid chromatography, [5] [6] [7] [8] estimation of ATV and RTV alone or combination with other antiretro viral drug in bulk and pharmaceutical dosage forms by ultraviolate(UV)-visible spectrophotometric method, [9] [10] [11] [12] [13] reversed phase-high performance liquid chromatography method, [14] [15] [16] [17] [18] [19] [20] high performance thin layer chromatographic. [21, 22] The aim of this work is to develop a simple, accurate and precise absorbance correction method by using UV spectrophotometry for the simultaneous estimation of ATV and RTV in combined tablet dosage. The method was validated for different parameters like linearity, accuracy, precision, robustness, ruggedness, limit of detection (LOD) and limit of quantification (LOQ) according to International conference of Harmonazation Guideline. [23] 
Materials and Methods

Instrument
The present work was carried out on Shimadzu UV-1700 double beam spectrophotometer with 1 cm path length supported by [Shimadzu, model-1700(Japan), UV-Probe software, version 2.31] was used for spectral measurements with 10 mm matched quartz cells.
Chemical and solvent
Standard of ATV and RTV were procured by Cipla Pharmaceutical Ltd. Methanol was purchased from Finar Chemicals Pvt. Ltd.
Method: Absorbance correction method
In this method, [24] absorbance of interfering component, i.e., absorbance of RTV was corrected from the total absorbance by the following formula: (2) where Cx and Cy are the concentrations of ATV and RTV in g/100 mL in the sample, respectively, A1 and A2 are the absorbance of the sample at λ1 (279 nm) and λ2 (240 nm), respectively, ax1 and ax2 are the specific absorptivities of ATV at λ1 (279 nm) and λ2 (240 nm), respectively, ay2 is the specific absorptivities of RTV at λ2 (240 nm).
Procedure
Solubility test
Solubility test for the drug was performed by using various solvents. The solvents include water, methanol, acetonitrile, 0.1 N HCl, and 0.1 N NaOH. However, methanol was chosen as a solvent for developing the method.
Preparation of standard stock solutions and calibration curve
Standard stock solutions of pure drug containing 1000 μg/mL of ATV and RTV were prepared separately in methanol. Standard stock solutions were further diluted with methanol to get working standard solutions of analytes in the concentration range of 30-90 and 10-30 μg/mL of ATV and RTV, respectively and scanned in the range of 200-400 nm.
Preparation of sample solution and formulation analysis
Twenty tablets were weighed accurately and a quantity of tablet powder equivalent to 30 mg of ATV (10 mg RTV) was weighed and dissolved in the 30 mL of methanol with the aid of ultrasonication for 10 min and the solution was filtered through Whatman paper no. 41 into a 100 mL volumetric flask. Filter paper was washed with solvent, adding washings to the volumetric flask; volume was made up to the mark with methanol. The solution was suitably diluted with methanol to get 30 μg/mL ATV and 
Results and Discussion
The proposed method was found to be simple, accurate, and economic for routine simultaneous estimation of these two drugs in combined dosage form. The values of relative standard deviation (RSD) are satisfactory low and recovery was closed to 100%, indicating reproducibility and accuracy of the method. This method gave excellent result and can be employed for routine analysis.
Assay of formulation
Absorbance correction method was found to be suitable to quantify ATV and RTV in tablet dosage form. Assay of ATV and RTV were found to be within IP limit [ Table 1 ].
Method validation Linearity
The calibration curves were constructed at optimum experimental conditions using absorbance values versus concentration in the range of 30-90 and 10-30 μg/mL for ATV and RTV, respectively. The results are reported in [ Table 2 ].
Recovery study
To check the accuracy of the method, recovery studies were carried out by the addition of standard drug solution to pre-analyzed sample solution at three different levels 80%, 100% and 120% [ Table 3 ].
Precision
Intra-day precision and inter-day precision were determined by analyzing ATV (30, 60 and 90 μg/mL) and RTV (10, 20 and 30 μg/mL) for 3 times on the same day and on different days. The results were reported in terms of %RSD [ Table 4 ].
LOD and LOQ
The LOD and LOQ were calculated using following formula:
Where, σ = standard deviation of response. S = slope of the calibration curve.
Specificity
The formulation was assayed in the presence of the excipients by the proposed methods. It was found that there is no interference of the excipients which justifies the specificity of the drug for the proposed method.
Conclusion
The proposed method is simple, specific, accurate and precise and hence can be used in routine for estimation of ATV and RTV in tablet dosage form. The percentage RSD for all parameters was found to be <2, which indicates the validity of the method and assay results obtained by this method are in fair agreement.
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